U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Nasal Type Extranodal NK/T-Cell Lymphoma

MedGen UID:
163128
•Concept ID:
C0854143
•
Neoplastic Process
Synonyms: Recurrent Angiocentric Lymphoma; Relapsed Angiocentric Lymphoma; Relapsed Nasal Type NK/T-Cell Lymphoma

Definition

The reemergence of nasal type extranodal NK/T-cell lymphoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Nasal Type Extranodal NK/T-Cell Lymphoma

Professional guidelines

PubMed

Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.
Yamaguchi M, Oguchi M, Suzuki R
Best Pract Res Clin Haematol 2018 Sep;31(3):315-321. Epub 2018 Jul 3 doi: 10.1016/j.beha.2018.07.002. PMID: 30213402
Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E, Kwong YL
Expert Rev Hematol 2016 Sep;9(9):861-71. Epub 2016 Jul 8 doi: 10.1080/17474086.2016.1206465. PMID: 27347812
Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol 2014 Jan;51(1):42-51. Epub 2013 Nov 15 doi: 10.1053/j.seminhematol.2013.11.007. PMID: 24468315

Recent clinical studies

Etiology

Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma.
Dong G, Liu X, Wang L, Yin W, Bouska A, Gong Q, Shetty K, Chen L, Sharma S, Zhang J, Lome-Maldonado C, Quintanilla-Martinez L, Li Y, Song JY, Zhang W, Shi Y, Wang J, Kong L, Wu X, Wang J, Liu HG, Kong L, Sun W, Liu W, Wang L, McKeithan TW, Iqbal J, Chan WC
Leukemia 2022 Aug;36(8):2064-2075. Epub 2022 Jun 13 doi: 10.1038/s41375-022-01623-z. PMID: 35697790Free PMC Article
Spectrum of cytomorphological features of extranodal NK/T-cell lymphoma, nasal type.
Kaur K, Kakkar A, Bhardwaj N, Sakthivel P, Singh CA, Jain D, Mathur SR, Iyer VK, Sood R
Cytopathology 2019 Jul;30(4):393-401. Epub 2019 May 6 doi: 10.1111/cyt.12705. PMID: 30980430
Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.
Yamaguchi M, Oguchi M, Suzuki R
Best Pract Res Clin Haematol 2018 Sep;31(3):315-321. Epub 2018 Jul 3 doi: 10.1016/j.beha.2018.07.002. PMID: 30213402
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R
J Clin Oncol 2011 Nov 20;29(33):4410-6. Epub 2011 Oct 11 doi: 10.1200/JCO.2011.35.6287. PMID: 21990393
Extranodal natural killer/T-cell lymphoma: advances in the management.
Jaccard A, Hermine O
Curr Opin Oncol 2011 Sep;23(5):429-35. doi: 10.1097/CCO.0b013e328349aba6. PMID: 21743325

Diagnosis

NK-Cell Lymphomas.
Chihara D, Oki Y
Cancer Treat Res 2019;176:163-184. doi: 10.1007/978-3-319-99716-2_8. PMID: 30596218
Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M, Suzuki R, Oguchi M
Blood 2018 Jun 7;131(23):2528-2540. Epub 2018 Mar 30 doi: 10.1182/blood-2017-12-791418. PMID: 29602763
Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E, Kwong YL
Expert Rev Hematol 2016 Sep;9(9):861-71. Epub 2016 Jul 8 doi: 10.1080/17474086.2016.1206465. PMID: 27347812
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R
J Clin Oncol 2011 Nov 20;29(33):4410-6. Epub 2011 Oct 11 doi: 10.1200/JCO.2011.35.6287. PMID: 21990393
Extranodal natural killer/T-cell lymphoma: advances in the management.
Jaccard A, Hermine O
Curr Opin Oncol 2011 Sep;23(5):429-35. doi: 10.1097/CCO.0b013e328349aba6. PMID: 21743325

Therapy

Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.
Yamaguchi M, Oguchi M, Suzuki R
Best Pract Res Clin Haematol 2018 Sep;31(3):315-321. Epub 2018 Jul 3 doi: 10.1016/j.beha.2018.07.002. PMID: 30213402
Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M, Suzuki R, Oguchi M
Blood 2018 Jun 7;131(23):2528-2540. Epub 2018 Mar 30 doi: 10.1182/blood-2017-12-791418. PMID: 29602763
Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol 2014 Jan;51(1):42-51. Epub 2013 Nov 15 doi: 10.1053/j.seminhematol.2013.11.007. PMID: 24468315
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R
J Clin Oncol 2011 Nov 20;29(33):4410-6. Epub 2011 Oct 11 doi: 10.1200/JCO.2011.35.6287. PMID: 21990393
Extranodal natural killer/T-cell lymphoma: advances in the management.
Jaccard A, Hermine O
Curr Opin Oncol 2011 Sep;23(5):429-35. doi: 10.1097/CCO.0b013e328349aba6. PMID: 21743325

Prognosis

Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.
Yamaguchi M, Oguchi M, Suzuki R
Best Pract Res Clin Haematol 2018 Sep;31(3):315-321. Epub 2018 Jul 3 doi: 10.1016/j.beha.2018.07.002. PMID: 30213402
The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.
de Mel S, Soon GS, Mok Y, Chung TH, Jeyasekharan AD, Chng WJ, Ng SB
Int J Mol Sci 2018 Jun 30;19(7) doi: 10.3390/ijms19071931. PMID: 29966370Free PMC Article
Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E, Kwong YL
Expert Rev Hematol 2016 Sep;9(9):861-71. Epub 2016 Jul 8 doi: 10.1080/17474086.2016.1206465. PMID: 27347812
Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol 2014 Jan;51(1):42-51. Epub 2013 Nov 15 doi: 10.1053/j.seminhematol.2013.11.007. PMID: 24468315
Extranodal natural killer/T-cell lymphoma: advances in the management.
Jaccard A, Hermine O
Curr Opin Oncol 2011 Sep;23(5):429-35. doi: 10.1097/CCO.0b013e328349aba6. PMID: 21743325

Clinical prediction guides

DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients.
Wang X, Hu J, Dong M, Ding M, Zhu L, Wu J, Sun Z, Li X, Zhang L, Li L, Wang X, Fu X, Wang G, Chen Q, Zhang M, Zhang X
Clin Transl Sci 2021 Jan;14(1):405-411. Epub 2020 Oct 12 doi: 10.1111/cts.12893. PMID: 33045134Free PMC Article
Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
Montes-Mojarro IA, Chen BJ, Ramirez-Ibarguen AF, Quezada-Fiallos CM, Pérez-Báez WB, Dueñas D, Casavilca-Zambrano S, Ortiz-Mayor M, Rojas-Bilbao E, García-Rivello H, Metrebian MF, Narbaitz M, Barrionuevo C, Lome-Maldonado C, Bonzheim I, Fend F, Steinhilber J, Quintanilla-Martinez L
Mod Pathol 2020 May;33(5):781-791. Epub 2019 Dec 10 doi: 10.1038/s41379-019-0415-5. PMID: 31822801
Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience.
Hattori Y, Murai T, Iwata H, Uchiyama K, Mimura M, Kato E, Murata R, Shibamoto Y
Jpn J Radiol 2016 Apr;34(4):292-9. Epub 2016 Feb 6 doi: 10.1007/s11604-016-0524-8. PMID: 26852128
Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol 2014 Jan;51(1):42-51. Epub 2013 Nov 15 doi: 10.1053/j.seminhematol.2013.11.007. PMID: 24468315
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R
J Clin Oncol 2011 Nov 20;29(33):4410-6. Epub 2011 Oct 11 doi: 10.1200/JCO.2011.35.6287. PMID: 21990393

Recent systematic reviews

The optimal timing of radiotherapy in the combination treatment of limited-stage extranodal natural killer/T-cell lymphoma, nasal type: an updated meta-analysis.
Cui Y, Yao Y, Chen M, Jiang Y, Ren Q
Ann Hematol 2021 Dec;100(12):2889-2900. Epub 2021 Oct 27 doi: 10.1007/s00277-021-04700-y. PMID: 34708280

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...